In addition, a CTL antimelanoma clone specific for Melan-A/MART-1 revealed significantly more killing of Bcl-2-overexpressing A02 melanoma cells in the presence of the potent Bcl-2 inhibitor ABT-737. Here, MLANA is linked to melanoma.